Form D Explorer

Inspect source fieldsReport a record issue

Form D — Anserine Labs, Inc.

0001231919-25-000168 · filed Aug 28, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other Technology filings

Offering

Industry
Other Technology
Exemptions
Rule 506(b)
Reported offering amount
$3,500,000
Reported amount sold
$3,439,997
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Anserine Labs, Inc.
CIK
2083708
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2025
Address
26 WESTWOOD HOUSE
LONDON, United Kingdom SW12 9RF
Phone
44 7584 887239

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗